[96a5a0]: / output / allTrials / identified / NCT00572572_identified.json

Download this file

393 lines (393 with data), 16.9 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
{
"info": {
"nct_id": "NCT00572572",
"official_title": "Phase III, Double-Blind, Placebo-Controlled, Crossover Study Evaluating Aprepitant in Combination With a 5HT3 & Dexamethasone in Patients With Germ Cell Tumors Undergoing 5 Day Cisplatin-Based Chemotherapy Regimen",
"inclusion_criteria": "* Histologic, serologic or clinical evidence of germ cell tumor.\n* Patients scheduled to receive a 5 day fractionated cisplatin-based combination chemotherapy on permitted regimens\n* Prior chemotherapy is allowed. Patients will be stratified based on previous treatment.\n* Male patients 15 years of age or older at time of registration.\n* Patient will provide written informed consent and authorization to release personal health information.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 15 Years",
"exclusion_criteria": "* No known history of anticipatory nausea or vomiting.\n* No use of another antiemetic agent within 72 hours prior to beginning chemotherapy.\n* No known central nervous system (CNS) metastasis.\n* No known hypersensitivity to any component of study regimen.\n* No concurrent participation in a clinical trial which involves another investigational agent.\n* No use of warfarin while on study.\n* No use of agents expected to induce the metabolism of aprepitant which include: Rifampin, Rifabutin, Phenytoin, Carbamazepine, and barbiturates.\n* No use of agents which may impair metabolism of aprepitant which include: Cisapride, macrolide antibiotics (Erythromycin, Clarithromycin, Azithromycin), azole antifungal agents (Ketoconazole, Itraconazole, Voriconazole, Fluconazole), Amifostine, Nelfinavir and Ritonavir.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Histologic, serologic or clinical evidence of germ cell tumor.",
"criterions": [
{
"exact_snippets": "Histologic ... evidence of germ cell tumor.",
"criterion": "germ cell tumor",
"requirements": [
{
"requirement_type": "evidence type",
"expected_value": "histologic"
}
]
},
{
"exact_snippets": "serologic ... evidence of germ cell tumor.",
"criterion": "germ cell tumor",
"requirements": [
{
"requirement_type": "evidence type",
"expected_value": "serologic"
}
]
},
{
"exact_snippets": "clinical evidence of germ cell tumor.",
"criterion": "germ cell tumor",
"requirements": [
{
"requirement_type": "evidence type",
"expected_value": "clinical"
}
]
}
]
},
{
"line": "* Patients scheduled to receive a 5 day fractionated cisplatin-based combination chemotherapy on permitted regimens",
"criterions": [
{
"exact_snippets": "scheduled to receive a 5 day fractionated cisplatin-based combination chemotherapy",
"criterion": "chemotherapy regimen",
"requirements": [
{
"requirement_type": "type",
"expected_value": "cisplatin-based combination"
},
{
"requirement_type": "schedule",
"expected_value": "5 day fractionated"
}
]
}
]
},
{
"line": "* Prior chemotherapy is allowed. Patients will be stratified based on previous treatment.",
"criterions": [
{
"exact_snippets": "Prior chemotherapy is allowed",
"criterion": "prior chemotherapy",
"requirements": [
{
"requirement_type": "allowance",
"expected_value": true
}
]
},
{
"exact_snippets": "Patients will be stratified based on previous treatment",
"criterion": "previous treatment",
"requirements": [
{
"requirement_type": "stratification",
"expected_value": true
}
]
}
]
},
{
"line": "* Male patients 15 years of age or older at time of registration.",
"criterions": [
{
"exact_snippets": "Male patients",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "male"
}
]
},
{
"exact_snippets": "15 years of age or older",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum age",
"expected_value": {
"operator": ">=",
"value": 15,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Patient will provide written informed consent and authorization to release personal health information.",
"criterions": [
{
"exact_snippets": "Patient will provide written informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "provision",
"expected_value": true
}
]
},
{
"exact_snippets": "authorization to release personal health information",
"criterion": "authorization to release personal health information",
"requirements": [
{
"requirement_type": "authorization",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "Must be MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 15 Years",
"criterions": [
{
"exact_snippets": "minimum age of 15 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 15,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* No known history of anticipatory nausea or vomiting.",
"criterions": [
{
"exact_snippets": "No known history of anticipatory nausea or vomiting.",
"criterion": "anticipatory nausea or vomiting",
"requirements": [
{
"requirement_type": "history",
"expected_value": false
}
]
}
]
},
{
"line": "* No use of another antiemetic agent within 72 hours prior to beginning chemotherapy.",
"criterions": [
{
"exact_snippets": "No use of another antiemetic agent within 72 hours prior to beginning chemotherapy.",
"criterion": "use of another antiemetic agent",
"requirements": [
{
"requirement_type": "time since last use",
"expected_value": {
"operator": ">=",
"value": 72,
"unit": "hours"
}
}
]
}
]
},
{
"line": "* No known central nervous system (CNS) metastasis.",
"criterions": [
{
"exact_snippets": "No known central nervous system (CNS) metastasis.",
"criterion": "central nervous system (CNS) metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No known hypersensitivity to any component of study regimen.",
"criterions": [
{
"exact_snippets": "No known hypersensitivity to any component of study regimen.",
"criterion": "hypersensitivity to study regimen components",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No concurrent participation in a clinical trial which involves another investigational agent.",
"criterions": [
{
"exact_snippets": "No concurrent participation in a clinical trial which involves another investigational agent.",
"criterion": "concurrent participation in a clinical trial",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "No concurrent participation in a clinical trial which involves another investigational agent.",
"criterion": "involvement of another investigational agent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No use of warfarin while on study.",
"criterions": [
{
"exact_snippets": "No use of warfarin while on study.",
"criterion": "warfarin use",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No use of agents expected to induce the metabolism of aprepitant which include: Rifampin, Rifabutin, Phenytoin, Carbamazepine, and barbiturates.",
"criterions": [
{
"exact_snippets": "No use of agents expected to induce the metabolism of aprepitant which include: Rifampin, Rifabutin, Phenytoin, Carbamazepine, and barbiturates.",
"criterion": "use of agents that induce the metabolism of aprepitant",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
},
{
"line": "* No use of agents which may impair metabolism of aprepitant which include: Cisapride, macrolide antibiotics (Erythromycin, Clarithromycin, Azithromycin), azole antifungal agents (Ketoconazole, Itraconazole, Voriconazole, Fluconazole), Amifostine, Nelfinavir and Ritonavir.",
"criterions": [
{
"exact_snippets": "No use of agents which may impair metabolism of aprepitant",
"criterion": "use of agents impairing metabolism of aprepitant",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Cisapride",
"criterion": "use of Cisapride",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "macrolide antibiotics (Erythromycin, Clarithromycin, Azithromycin)",
"criterion": "use of macrolide antibiotics",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "azole antifungal agents (Ketoconazole, Itraconazole, Voriconazole, Fluconazole)",
"criterion": "use of azole antifungal agents",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Amifostine",
"criterion": "use of Amifostine",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Nelfinavir",
"criterion": "use of Nelfinavir",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
},
{
"exact_snippets": "Ritonavir",
"criterion": "use of Ritonavir",
"requirements": [
{
"requirement_type": "presence",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}